• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国公共卫生服务署提高死亡风险供体指定对器官利用的影响。

Impact of US Public Health Service increased risk deceased donor designation on organ utilization.

机构信息

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Health Resources and Services Administration, Rockville, Maryland.

出版信息

Am J Transplant. 2019 Sep;19(9):2560-2569. doi: 10.1111/ajt.15388. Epub 2019 May 3.

DOI:10.1111/ajt.15388
PMID:30959569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6864734/
Abstract

Under US Public Health Service guidelines, organ donors with risk factors for human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV) are categorized as increased risk donors (IRD). Previous studies have suggested that IRD organs are utilized at lower rates than organs from standard risk donors (SRD), but these studies were conducted prior to universal donor nucleic acid test screening. We conducted risk-adjusted analyses to determine the effect of IRD designation on organ utilization using 2010-2017 data (21 626 heart, 101 160 kidney, 52 714 liver, and 16 219 lung recipients in the United States) from the Organ Procurement and Transplantation Network. There was no significant difference (P < .05) between risk-adjusted utilization rates for IRD vs SRD organs for adult hearts and livers and pediatric kidneys, livers, and lungs. Significantly lower utilization was found among IRD adult kidneys, lungs, and pediatric hearts. Analysis of the proportion of transplanted organs recovered from IRD by facility suggests that a subset of facilities contribute to the underutilization of adult IRD kidneys. Along with revised criteria and nomenclature to identify donors with HIV, HBV, or HCV risk factors, educational efforts to standardize informed consent discussions might improve organ utilization.

摘要

根据美国公共卫生服务指南,具有人类免疫缺陷病毒 (HIV)、乙型肝炎病毒 (HBV) 或丙型肝炎病毒 (HCV) 风险因素的器官捐赠者被归类为增加风险供体 (IRD)。先前的研究表明,IRD 器官的利用率低于标准风险供体 (SRD) 的器官,但这些研究是在普遍进行供体核酸检测筛查之前进行的。我们使用 2010-2017 年美国器官获取和移植网络的数据(21626 例心脏、101160 例肾脏、52714 例肝脏和 16219 例肺移植受者)进行了风险调整分析,以确定 IRD 分类对器官利用的影响。成人心脏和肝脏以及儿科肾脏、肝脏和肺的 IRD 与 SRD 器官的风险调整利用率之间没有显著差异 (P<0.05)。IRD 成人肾脏、肺和儿科心脏的利用率明显较低。对设施从 IRD 回收的移植器官比例的分析表明,一部分设施导致成人 IRD 肾脏的利用率降低。随着识别具有 HIV、HBV 或 HCV 风险因素的供体的标准和命名法的修订,开展标准化知情同意讨论的教育工作可能会提高器官利用率。

相似文献

1
Impact of US Public Health Service increased risk deceased donor designation on organ utilization.美国公共卫生服务署提高死亡风险供体指定对器官利用的影响。
Am J Transplant. 2019 Sep;19(9):2560-2569. doi: 10.1111/ajt.15388. Epub 2019 May 3.
2
Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.已故器官捐献者和 PHS 风险识别:对器官使用和结果的影响。
Transplantation. 2017 Jul;101(7):1670-1678. doi: 10.1097/TP.0000000000001716.
3
The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year.“PHS 增加风险”标签与每年数百个器官未被利用有关。
Transplantation. 2017 Jul;101(7):1666-1669. doi: 10.1097/TP.0000000000001673.
4
Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.实体器官移植中传染病供体器官传播风险增加的利用:疾病传播与安全性的回顾性分析
Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12791. Epub 2017 Nov 3.
5
Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.评估实体器官捐献者和监测人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒感染的移植受者-美国卫生与公众服务部 2020 年指南。
MMWR Recomm Rep. 2020 Jun 26;69(4):1-16. doi: 10.15585/mmwr.rr6904a1.
6
Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in Public Health Service increased risk donors.量化公共卫生服务中高危献血者中未检出的 HIV、乙肝病毒或丙肝病毒感染的风险。
Am J Transplant. 2019 Sep;19(9):2583-2593. doi: 10.1111/ajt.15393. Epub 2019 May 10.
7
Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017.美国疾病预防控制中心 2014-2017 年调查的通过器官移植传播的乙型肝炎和丙型肝炎病毒感染。
Am J Transplant. 2019 Sep;19(9):2570-2582. doi: 10.1111/ajt.15352. Epub 2019 Apr 29.
8
Organ transplantation from "increased infectious risk donors": the experience of the Nord Italia Transplant program - A retrospective study.从“增加感染风险供者”进行器官移植:Nord Italia 移植项目的经验——一项回顾性研究。
Transpl Int. 2018 Feb;31(2):212-219. doi: 10.1111/tri.13086. Epub 2017 Nov 7.
9
Organ Nonutilization Following Revision to the Public Health Service Donor Risk Criteria for HIV, HCV, or HBV Transmission.修订公共卫生服务机构关于人类免疫缺陷病毒(HIV)、丙型肝炎病毒(HCV)或乙型肝炎病毒(HBV)传播的捐赠者风险标准后器官未被利用的情况。
Transplantation. 2024 Jun 1;108(6):1440-1447. doi: 10.1097/TP.0000000000004929. Epub 2024 Feb 16.
10
Impact of the OPTN transmissible diseases policy and US PHS increased risk donor guidelines on living donor candidates.OPTN 传染病政策和美国 PHS 增加风险供体指南对活体供体候选人的影响。
Am J Transplant. 2019 Dec;19(12):3233-3239. doi: 10.1111/ajt.15541. Epub 2019 Aug 14.

引用本文的文献

1
The Impact of Critical Care Quarantine on the Residual Risk of Unexpected Organ Donor Blood-borne Virus Infection.重症监护隔离对意外器官捐献者血源病毒感染残余风险的影响。
Transplant Direct. 2025 Aug 13;11(9):e1843. doi: 10.1097/TXD.0000000000001843. eCollection 2025 Sep.
2
Organ and tissue donation and sexual and gender minoritized persons: time for positive change.器官和组织捐赠与性少数和性别少数群体:积极变革的时刻到了。
Can J Anaesth. 2025 Aug;72(8):1187-1191. doi: 10.1007/s12630-025-03009-y. Epub 2025 Jul 15.
3
Reasons for donor heart offer refusal in the United States: Results from 14,132 transplant clinician surveys in the Donor Heart Study.美国供体心脏供体拒绝的原因:来自“供体心脏研究”中14132名移植临床医生调查的结果。
J Heart Lung Transplant. 2025 Jul;44(7):1075-1082. doi: 10.1016/j.healun.2025.02.1698.
4
Increased Infectious Risk Donor Status and Equity-Relevant Predictors of Organ Donation Organization Approach and Caregiver Consent for Deceased Organ Donation in a Canadian Province (2015-2021).加拿大某省(2015 - 2021年)器官捐赠组织方法及死者器官捐赠照料者同意书的感染风险增加捐赠者状态与公平相关预测因素
Clin Transplant. 2024 Dec;38(12):e70058. doi: 10.1111/ctr.70058.
5
Organ Nonutilization Following Revision to the Public Health Service Donor Risk Criteria for HIV, HCV, or HBV Transmission.修订公共卫生服务机构关于人类免疫缺陷病毒(HIV)、丙型肝炎病毒(HCV)或乙型肝炎病毒(HBV)传播的捐赠者风险标准后器官未被利用的情况。
Transplantation. 2024 Jun 1;108(6):1440-1447. doi: 10.1097/TP.0000000000004929. Epub 2024 Feb 16.
6
Effectiveness of education and attitudes toward different types of deceased donor kidneys: Survey analysis of single-center experience.不同类型已故供体肾脏的教育和态度的效果:单中心经验的调查分析。
Front Public Health. 2023 Mar 29;11:1116823. doi: 10.3389/fpubh.2023.1116823. eCollection 2023.
7
Recently Acquired Blood-borne Virus Infections in Australian Deceased Organ Donors: Estimation of the Residual Risk of Unexpected Transmission.澳大利亚已故器官捐献者近期获得的血源病毒感染:意外传播残余风险的评估
Transplant Direct. 2023 Feb 17;9(3):e1447. doi: 10.1097/TXD.0000000000001447. eCollection 2023 Mar.
8
SARS-CoV-2 NAT+ donors for pediatric solid organ transplant recipients-Are they safe and provide good outcomes?用于小儿实体器官移植受者的新冠病毒核酸检测阳性供体——他们安全且能带来良好预后吗?
Pediatr Transplant. 2022 Dec;26(8):e14406. doi: 10.1111/petr.14406. Epub 2022 Oct 4.
9
Donor Utilization in the Recent Era: Effect of Sex, Drugs, and Increased Risk.近期供者利用情况:性别、药物和风险增加的影响。
Circ Heart Fail. 2022 Jul;15(7):e009547. doi: 10.1161/CIRCHEARTFAILURE.122.009547. Epub 2022 Jun 21.
10
Prevalence of Blood-Borne Viruses and Predictors of Risk in Potential Organ Donors in Australia.澳大利亚潜在器官捐献者中血源病毒的流行情况及风险预测因素。
Transpl Int. 2022 May 3;35:10395. doi: 10.3389/ti.2022.10395. eCollection 2022.

本文引用的文献

1
Characteristics of Deceased Solid Organ Donors and Screening Results for Hepatitis B, C, and Human Immunodeficiency Viruses - United States, 2010-2017.2010-2017 年美国已故实体器官捐献者的特征和乙型肝炎、丙型肝炎及人类免疫缺陷病毒的筛查结果。
MMWR Morb Mortal Wkly Rep. 2019 Jan 25;68(3):61-66. doi: 10.15585/mmwr.mm6803a2.
2
The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States: A National Registry Study.美国的药物过量流行和已故供体器官移植:国家登记研究。
Ann Intern Med. 2018 May 15;168(10):702-711. doi: 10.7326/M17-2451. Epub 2018 Apr 17.
3
What are the outcomes of declining a public health service increased risk liver donor for patients on the liver transplant waiting list?拒绝增加风险的公共卫生服务肝脏供体对肝移植等待名单上的患者有何影响?
Liver Transpl. 2018 Apr;24(4):497-504. doi: 10.1002/lt.25009.
4
Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.拒绝什么?与降低增加的传染性风险肾脏相关的患者结果。
Am J Transplant. 2018 Mar;18(3):617-624. doi: 10.1111/ajt.14577. Epub 2017 Dec 5.
5
Cultural competency of a mobile, customized patient education tool for improving potential kidney transplant recipients' knowledge and decision-making.一种用于提高潜在肾移植受者知识水平和决策能力的移动定制患者教育工具的文化胜任力。
Clin Transplant. 2017 May;31(5). doi: 10.1111/ctr.12944. Epub 2017 Apr 9.
6
The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year.“PHS 增加风险”标签与每年数百个器官未被利用有关。
Transplantation. 2017 Jul;101(7):1666-1669. doi: 10.1097/TP.0000000000001673.
7
Living Donor Kidney Transplantation: Improving Education Outside of Transplant Centers about Live Donor Transplantation--Recommendations from a Consensus Conference.活体供肾移植:改善移植中心以外关于活体供肾移植的教育——共识会议的建议
Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1659-69. doi: 10.2215/CJN.00950115. Epub 2015 Jun 26.
8
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.弥合差距:美国和加拿大接受治疗的 HIV 阳性个体的预期寿命增加。
PLoS One. 2013 Dec 18;8(12):e81355. doi: 10.1371/journal.pone.0081355. eCollection 2013.
9
PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.通过器官移植减少人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒传播的公共卫生服务指南。
Public Health Rep. 2013 Jul;128(4):247-343. doi: 10.1177/003335491312800403.
10
Centers for Disease Control 'high-risk' donors and kidney utilization.疾病预防控制中心“高危”供者与肾脏利用。
Am J Transplant. 2010 Feb;10(2):416-20. doi: 10.1111/j.1600-6143.2009.02931.x. Epub 2009 Dec 2.